| +380 44 495-10-14 |
rus | eng
|
|
02.04.2011
From 1st of April, 2011 Merck Serono S.A., Switzerland, authorized and gave exclusive rights to Sona-Pharm LLC to represent pharmaceutical products (Gonal-f, Ovitrelle, Cetrotide, Crinone, Luveris) on the territory of Republic of Kazakhstan.From 1st of April, 2011 Merck Serono S.A., Switzerland, authorized and gave exclusive rights to Sona-Pharm LLC to represent pharmaceutical products (Gonal-f, Ovitrelle, Cetrotide, Crinone, Luveris) on the territory of Republic of Kazakhstan. Within the agreement Sona-Pharm LLC is authorized to provide full regulatory support for the products above mentioned including registration, renewal, pharmacovigilance, as well as to realize commercial activities, management of distribution, to perform marketing activities according to global marketing plan.
|
15.11.2011
04.06.2011
02.04.2011
29.05.2010
21.05.2010
|
||||||||||||||||||||||||||||||||||||||||||||
|
Sona-Pharm LLC
Ukraine, 03680 Kyiv Mykoly Grinchenka Str., 4 Теl: +38 044 495 10 14 Fax: +38 044 495 10 15 office@sona-pharm.com.ua |
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||